Literature DB >> 19581503

Angiotensin-converting enzyme and dipeptidyl peptidase IV inhibitors: an increased risk of angioedema.

Eric Grouzmann, Françoise Livio, Thierry Buclin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19581503     DOI： 10.1161/HYPERTENSIONAHA.109.135244

Source DB:  PubMed          Journal:  Hypertension        ISSN： 0194-911X            Impact factor:   10.190


× No keyword cloud information.
  10 in total

1.  Sitagliptin augments angiotensin II-induced renal vasoconstriction in kidneys from rats with metabolic syndrome.

Authors:  David S Tofovic; Victor P Bilan; Edwin K Jackson
Journal:  Clin Exp Pharmacol Physiol       Date:  2010-03-30       Impact factor: 2.557

Review 2.  Dipeptidylpeptidase-4 inhibitors (gliptins): focus on drug-drug interactions.

Authors:  André J Scheen
Journal:  Clin Pharmacokinet       Date:  2010-09       Impact factor: 6.447

Review 3.  Glycaemic Control in Patients Undergoing Percutaneous Coronary Intervention: What Is the Role for the Novel Antidiabetic Agents? A Comprehensive Review of Basic Science and Clinical Data.

Authors:  Annunziata Nusca; Francesco Piccirillo; Federico Bernardini; Aurelio De Filippis; Federica Coletti; Fabio Mangiacapra; Elisabetta Ricottini; Rosetta Melfi; Paolo Gallo; Valeria Cammalleri; Nicola Napoli; Gian Paolo Ussia; Francesco Grigioni
Journal:  Int J Mol Sci       Date:  2022-06-30       Impact factor: 6.208

4.  Drug-induced angioedema: experience of Italian emergency departments.

Authors:  G Bertazzoni; M T Spina; M G Scarpellini; F Buccelletti; M De Simone; M Gregori; V Valeriano; F R Pugliese; M P Ruggieri; M Magnanti; B Susi; L Minetola; L Zulli; F D'Ambrogio
Journal:  Intern Emerg Med       Date:  2013-11-09       Impact factor: 3.397

Review 5.  "Nuts and Bolts" of Laboratory Evaluation of Angioedema.

Authors:  Henriette Farkas; Nóra Veszeli; Erika Kajdácsi; László Cervenak; Lilian Varga
Journal:  Clin Rev Allergy Immunol       Date:  2016-10       Impact factor: 8.667

6.  Role of RACK1 in the differential proliferative effects of neuropeptide Y(1-36) and peptide YY(1-36) in SHR vs. WKY preglomerular vascular smooth muscle cells.

Authors:  Dongmei Cheng; Xiao Zhu; Delbert G Gillespie; Edwin K Jackson
Journal:  Am J Physiol Renal Physiol       Date:  2013-01-09

Review 7.  Factors affecting the development of adverse drug reactions (Review article).

Authors:  Muaed Jamal Alomar
Journal:  Saudi Pharm J       Date:  2013-02-24       Impact factor: 4.330

8.  Sitagliptin-Moringa oleifera coadministration did not delay the progression nor ameliorated functional and morphological anomalies in alloxan-induced diabetic nephropathy.

Authors:  Comfort Omoigemete Olurishe; Helen Ochuko Kwanashie; Abdulkadiri Umar Zezi; Nuhu Mohammed Danjuma; Bisalla Mohammed
Journal:  Indian J Pharmacol       Date:  2017 Sep-Oct       Impact factor: 1.200

Review 9.  Angioedema associated with dipeptidyl peptidase-IV inhibitors.

Authors:  Nicoletta Cassano; Eustachio Nettis; Elisabetta Di Leo; Francesca Ambrogio; Gino A Vena; Caterina Foti
Journal:  Clin Mol Allergy       Date:  2021-12-06

Review 10.  The opioid effects of gluten exorphins: asymptomatic celiac disease.

Authors:  Leo Pruimboom; Karin de Punder
Journal:  J Health Popul Nutr       Date:  2015-11-24       Impact factor: 2.000
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.